Which medicine should have priority?
Prioritizing according to NICE. Dr Amanda Adler MD, PhD, FRCP, NICE, United Kingdom
The pharmacoeconomic perspective. Kjeld Møller Pedersen, Professor of Public and Health Economics, SDU
A perspective on prioritizing in oncology. Lars Henrik Jensen, Consultant, PhD, Department of Oncology, Vejle Hospital
A Danish model. Hanne Rolighed Christensen, Consultant, Professor, Head of Department, PhD, Department of Clinical Pharmacology, Bispebjerg Hospital